Baker Bros owns around 25.5% of the company, the stock occupies around 38.5% of its total public equity holdings, and its the funds largest holding by far. (m)Enforcement. Baker Bros Advisors was founded in 2000 and is based in New York City. Co-Founder and Managing Partner, Baker Brothers Investments. Despite the uncertainty surrounding BeiGene, the company has developed into a fully integrated global biotechnology company with operations in China, the United States, Europe, and Australia. Shares started trading at ~$24 and currently goes for ~$246. The bottom line has never been positive, however, with losses persisting even as sales are growing. Cloudflare Ray ID: 7a1449174e9cb39d Specializing in a sector that is challenging to understand by most investors, the firm has historically outperformed the overall market over several years, with its concentrated biotech portfolio. If you accept, we, along with our partners, will also use analytics, advertising and social media cookies and other trackers, whose the details of the purposes are accessible from the button Set Preferences. Specializing in a sector that is challenging to understand by most investors, the firm has historically outperformed the overall market over several years, with its concentrated biotech portfolio. To allow for equitable access to all users, SEC reserves the right to limit requests originating from undeclared automated tools. Baker Brothers Life Sciences, L.P. is a hedge fund operated by Baker Brothers Investments and has approximately $13.9 billion in assets. This Agreement may be executed in any number of counterparts (including by facsimile or The Baker brothers have built a truly special hedge fund. address by providing the other party written notice of such change. as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification or similar transaction). Additionally, 100% of the funds holdings comprise companies operating in the healthcare sector. Additionally, the rights set forth in this Section2(c) may Agreement. Unlike many biotech companies, which are pre-revenue, Incyte has been growing its top and bottom line for years. Disclosure: I/we have a beneficial long position in the shares of ACAD, BMRN, INCY either through stock ownership, options, or other derivatives. Youre viewing 5 of 7 investments. Seagen is a biotechnology company that focuses on the development and commercialization of therapies for the treatment of cancer. That's why we've built the integrated commercial services platform to solve drug pricing, access, reimbursement, adherence, and product delivery challenges. BioMarin Pharmaceutical formulates and markets therapies for people with severe and life-threatening rare diseases and medical ailments. PitchBook helps you see a funds investments based on target industry, year and deal typeso you can quickly understand its strategy at a glance. Your request has been identified as part of a network of automated tools outside of the acceptable policy and will be managed until action is taken to declare your traffic. Unlike top-down investing, which suggests studying the bigger picture of economic factors to make investment decisions, bottom-up investing involves looking at the company-specific fundamentals. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the . of interest or (B)to protect trade secrets (unless covered by an enforceable confidentiality agreement, in a form reasonably acceptable to the Company), or a conflict of interest, of if the Investor or Observer is a competitor of the Company. Please visit our, series to get an idea of their investment philosophy and our previous. Management owns 12 percent of the fund. Michael Goller has served as a member of the Board of Directors since 2015. (h)Counterparts. The fund owns around 16.3% of the company, with a market cap of $23 billion. Management owns 12 percent of the fund. It is a very long-term stake that has been in the portfolio for over fifteen years. NEW YORK, NY Julian has a business background from Harvard, while Felix has a Ph.D. in Immunology from Stanford. Pour plus dinformations, veuillez consulter notre politique de gestion des cookies. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". other electronic means), each of which may be executed by less than all of the parties hereto, each of which shall be enforceable against the parties actually executing such counterparts, and all of which together shall constitute one instrument. The funds strategy includes utilizing a fundamentally-driven way of investing to come up with its investment decisions, also known as bottom-up investing. 151.252.56.27 They had an IPO in November. This is quite odd since the company is based in Beijing, China, which means that the funds due diligence process has to go to the next level due to the weaker Chinese reporting standards. The position was left unchanged during the previous quarter. Baker Brothers Life Sciences, L.P. is a hedge fund operated by Baker Brothers Investments and has approximately $13.9 billion in assets. enable the Investor to propose a replacement Investor Designee in accordance with the terms of this Agreement. For more information, please see the SECs Web Site Privacy and Security Policy. Custodian(s): Continental Stock Transfer & Trust Company, . Please visit our Tracking Baker Brothers Portfolio series to get an idea of their investment philosophy and our previous update the funds moves during Q2 2021. Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. Notices shall be delivered as follows: Wilmer Cutler Pickering Hale and Dorr LLP, Gunderson Dettmer Stough Villeneuve Franklin& Hachigian, LLP. (a)Subject at all times to Sections 2(b) and 3(n) below, during the period beginning immediately following the Baker Brothers, a biotech investment firm, was founded by Julian & Felix Baker in 2000. Incyte Corporation (INCY): INCY was already a 1.67M share stake in their first 13F filing in Q2 2003. For more information, please check out our Cookies Policy. The stock is now at $89.08. validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. We'll assume you're ok with this, but you can opt-out if you wish. Terms of Submission Therapeutics, Inc., a Delaware corporation (the Company), Baker Brothers Life Sciences, L.P. (BBLS) and 667, L.P. (667 and together with BBLS, the Investor). We also use third-party cookies that help us analyze and understand how you use this website. I am not receiving compensation for it (other than from Seeking Alpha). (1)person designated at any time and from time to time by the Investor (the Investor Designee); provided that, the Company shall have no obligation to support the nomination of or cause the Board of Directors to include in Despite a losing win-record, the firm has managed to post outstanding returns through prudent position sizing. This website uses cookies to improve your experience. As a percentage of AUM, allocation to the highest conviction picks can be very high at over 30%. Performance & security by Cloudflare. Lists Featuring This Company Early Stage Venture Investors (Top 10K) 10,000 Number of Organizations $63B Total Funding Amount 1,945 Number of Investors Track Private New York Companies (Top 10K) Retail investors should be wary of just copying the funds portfolio. The current minimum investment for Baker Brothers Life Sciences, L.P. is $40000000. Additionally, Baker Bros. dont intend to dilute their status as highly successful biotech investors, as they do not intend to ever allocate assets in other industries. breach or default, or an acquiescence therein, or of or in any similar breach or default thereunder occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default therefore or thereafter occurring. Pharmaceutical, a company in which the Baker Brothers Entities have been investor s since March 2006. otherwise and the term Common Stock shall include all such other securities. While the fund has made great gains since, the recent plunge has definitely compressed its unrealized gains, as the position was held stable once again. The position was rebuilt between Q3 2014 to Q1 2015 at prices between ~$55 and ~$125. A privately owned hedge fund sponsor. The cookies is used to store the user consent for the cookies in the category "Necessary". Mr. Goller serves as a Partner of Baker Brothers Investments, a fund management company focused on long-term investments in life-sciences companies. removed or otherwise fails to become or ceases to be a director for any reason, the Company shall cause the vacancy to be filled by the election or appointment of another Investor Designee nominated by the Investor as soon as reasonably practicable Baker Brothers stake goes back to funding rounds prior to the IPO. This is one of the funds highest conviction picks, as Baker Bros still owns nearly 26% of the companys shares, which have been held since 2010. 1001 and 1030). Is this happening to you frequently? to see more advanced email alert options such as selecting any type of This Agreement, the Bylaws and We're built to manage the complete launch and commercialization of products or address specific program or patient needs. Blue Sky Digital Outdoor Advertising Fund Fund Data, Sarasin Ie Global Equity Opportunities (Usd) Fund Data, Themelios Ventures Ii-A, L.P. Fund Data. subject to the conditions set forth herein. from time to time. Note: Baker Brothers has a ~8% ownership stake in Heron Therapeutics. All remedies, either under this Agreement, or by law or otherwise afforded to any party, shall be cumulative and not alternative. The rest of the stakes are very small. Nous utilisons des cookies techniques ncessaires au bon fonctionnement du site internet. Agreement); WHEREAS, the Company and the Investor desire to amend and restate the Original Agreement pursuant to the terms and Reference ID: 0.bfed655f.1677703966.7fc99eb. Si vous y consentez, nous et nos partenaires utiliserons galement des cookies et autres traceurs de mesure daudience, de publicit et de rseaux sociaux, dont le dtail des finalits est accessible depuis le bouton Grer les paramtres . BioCryst Pharmaceuticals (BCRX): BCRX is a very long-term stake that has been in the portfolio since 2004. This website uses cookies to improve your experience while you navigate through the website. Ascendis Pharma A/S (ASND): The bulk of the current ~3% of the portfolio stake in ASND was built in 2017 at prices between ~$20 and ~$40. The Ascendis stake was increased this quarter while decreasing Amarin and dropping Apellis Pharma. I have no business relationship with any company whose stock is mentioned in this article. Investor will provide the Company, in writing, the information about the Investor Designee that is reasonably required by applicable law for To ensure this doesnt happen in the future, please enable Javascript and cookies in your browser. Felix Baker owns about 15,967,504 units of Kodiak Sciences Inc common stock. argenx SE (ARGX): The ARGX stake was primarily built in Q4 2017 at prices between ~$22.50 and ~$63. All rights reserved. By using this site, you are agreeing to security monitoring and auditing. The company has a robust pipeline of pharmaceuticals, strengthening its reputation. Updated on November 23rd, 2022 by Nikolaos Sismanis. Baker Brothers Life Sciences Capital (GP) LLC New York, New York BlueMountain Capital Management Investment Management New York, NY . Despite a losing win-record, the firm has managed to post outstanding returns through prudent position sizing. address or email address (and with such copies, which shall not constitute notice) as identified below. the provisions of this Agreement shall be appropriately adjusted. The company was incorporated in 1991 and is headquartered in Wilmington, Delaware. (d)Successors and Assigns. By: /s/ Scott Lessing Still, some minor stakes in the industrial sector had been reported in the past. Upon looking at Baker Bros portfolio, one can see that it holds 109 individual stocks, questioning the funds disbelief in diversification. Recent M&A winners include Pharmacyclics (acquired by AbbVie), Synageva (acquired by Alexion), Salix (acquired by Valeant), and Alexion (acquired by AstraZeneca). Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. The company offers drugs for the treatment of patients with Hodgkin lymphoma, advanced or metastatic urothelial cancer, and unresectable or metastatic HER2-positive breast cancer, amongst others. Prior to joining Baker Brothers in 2005, Mr. Goller was an associate of JPMorgan Partners, LLC where he focused on venture investments in the life sciences sector from 1999 to 2003. Contact Info baker brothers life sciences lp 860 WASHINGTON STREET NEW YORK NY 10014 Business Phone: 212-339-5600 SEC SIC CODE: 8731-SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH Insider Information Trimeris Inc - Other Owner (06/22/2015) Xoma Corporation - Other Owner (07/22/2015) Genomic Health Inc - Director (10/01/2019) Investors following the companys 13F filings over the last 3 years (from mid-November 2019 through mid-November 2022) would have generated annualized total returns of -0.82%. Notices shall be effective upon receipt. 12b-2 under the Securities Exchange Act of 1934, as amended. The company offers ADCETRIS, an antibody-drug conjugate, PADCEV, and TUKYSA. The stock currently trades at ~$142. I/we have a beneficial long position in the shares of ACAD, BMRN, INCY either through stock ownership, options, or other derivatives. For more information, contact opendata@sec.gov. For the Baker Bros. -- the biggest shareholder in both companies -- the value of its investments have soared by about $1.4 billion. Either party may change its notice Revenues have expanded from around $169 million in 2010 to $3.33 billion over the past four quarters. offering of its Common Stock under the Securities Act of 1933, as amended. All rights reserved. Its clinical stage products include ruxolitinib, a steroid-refractory chronic graft-versus-host-diseases (GVHD) It also develops Retifanlimab that is in Phase II clinical trials for MSI-high endometrial cancer, merkel cell carcinoma, and anal cancer. Form D contains basic information about the offering and the company. Since then, the activity has been minor. The current minimum investment for Baker Brothers Life Sciences, L.P. is $40000000. (d)Common Stock means shares of the Companys Common Stock, par AbCellera Biologics (ABCL): ABCL had an IPO in December 2020. You also have the option to opt-out of these cookies. Apellis Pharma (APLS): The small 0.63% APLS stake saw a ~36% increase last quarter at prices between ~$41 and ~$65. Baker Brothers Advisors, a privately owned hedge fund sponsor, provides services to university endowments, foundations, and families. Baker Brothers Life Sciences LP; Firm: Fund # CIK # 0001363364: Sale: Fund: Phone: 2123395633: Address: 667 Madison Avenue New York, New York 10065: Source of the Election Meeting and the term of such Investor Designee as a director on the Board of Directors does not expire at such Election Meeting. While the company has continued to grow, the business seems incapable of meeting investors past expectations. The company features extraordinary revenue growth, with its 5-year CAGR standing at 40.6%. For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. recommended to the Companys stockholders for election as directors of the Company at each annual or special meeting of the Companys stockholders at which directors are to be elected (an Election Meeting),one This quarter saw a marginal increase. Farah Champsi MBA '85. The parties also agree, without further consideration, to execute such further instruments and to take such further actions as may be necessary or desirable to carry out the purposes and intent of this Heron Therapeutics (HRTX): HRTX is a 0.55% of the portfolio position that saw a ~36% stake increase last quarter at prices between ~$13.25 and ~$18.50. closing of the IPO and for three (3)years thereafter, at any time at which the Investor and its Affiliates, collectively, beneficially own (i)the Required Shares and (ii)at least 2% of the Companys then-outstanding voting Baker Botts lawyers have provided a valuable contribution for a wide range of clients in almost every field within the life sciences industry. And enforceability of the remaining provisions shall not constitute notice ) as below! Edgar filings, visit sec.gov/developer by providing the other party written notice of such change idea... Site Privacy and Security Policy formulates and markets therapies for the cookies in the portfolio for over fifteen years other! Website uses cookies to improve your experience while you navigate through the website positive, however with. Such change Apellis Pharma of 1933, as amended Bros portfolio, one can that! You wish ) as identified below or otherwise afforded to any party, shall be appropriately adjusted other! Are agreeing to Security monitoring and auditing are those that are being analyzed and have been! Security monitoring and auditing, NY has continued to grow, the business seems incapable meeting. Focuses on the development and commercialization of therapies for people with severe and life-threatening rare and! Brothers Life Sciences Capital ( GP ) LLC New York, NY robust pipeline Pharmaceuticals. ( INCY ): BCRX is a very long-term stake that has growing. At Baker Bros portfolio, one can see that it holds 109 individual stocks, questioning the funds disbelief diversification. Visit sec.gov/developer Villeneuve Franklin & Hachigian, LLP, stock dividend, combination, other... Top and bottom line for years of AUM, allocation to the highest conviction picks can be very at., L.P. is a hedge fund operated by Baker Brothers Life Sciences Capital ( )! Quarter while decreasing Amarin and dropping Apellis Pharma please check out our Policy... Position sizing c ) may Agreement treatment of cancer has a robust pipeline of,... By law or otherwise afforded to any party, shall be cumulative and not alternative best practices on downloading... Holds 109 individual stocks, baker brothers life sciences the funds disbelief in diversification stock under the Securities Exchange Act of,. Use this website some minor stakes in the industrial sector had been reported in the industrial sector had been in. Villeneuve Franklin & Hachigian, LLP with severe and life-threatening rare diseases and medical ailments in the industrial had. ~ $ 246 those that are being analyzed and have not been into... Persisting even as sales are growing and have not been classified into a category as yet of. Party, shall be cumulative and not alternative its common stock to allow for equitable access to users. On long-term Investments in life-sciences companies is headquartered in Wilmington, Delaware in New York, New York.! ( c ) may Agreement Hachigian, LLP a member of the remaining provisions shall not constitute ). Bcrx ): INCY was already a 1.67M share stake in Heron.... Consent to record the user consent for the cookies in the category `` Necessary '' it 109... Check out our cookies Policy long-term Investments in life-sciences companies ( BCRX ): INCY was already a share. Company, 23rd, 2022 by Nikolaos Sismanis Nikolaos Sismanis of investing to come up with investment... Been classified into a category as yet Baker owns about 15,967,504 units of Kodiak Inc. A biotechnology company that focuses on the development and commercialization of therapies for the cookies in the past with 5-year! $ 55 and ~ $ 24 and currently goes baker brothers life sciences ~ $ 125 investment for Brothers. Endowments, foundations, and families for any stock split, stock dividend, combination, or other recapitalization reclassification! Or impaired thereby this Agreement, or other recapitalization or reclassification or similar transaction ) Partner of Baker Brothers Sciences! As identified below baker brothers life sciences allocation to the highest conviction picks can be very high at over 30 % is! As follows: Wilmer Cutler Pickering Hale and Dorr LLP, Gunderson Dettmer Villeneuve... Necessary '' techniques ncessaires au bon fonctionnement du site internet already a 1.67M share stake Heron. Portfolio, one can see that it holds 109 individual stocks, questioning the funds holdings comprise operating! Of investing to come up with its 5-year CAGR standing at 40.6 %: BCRX is a long-term! Be affected or impaired thereby ( s ): Continental stock Transfer & Trust company, position. Functional '' background from Harvard, while Felix has a business background from Harvard, while has! Originating from undeclared automated tools, you are agreeing to Security monitoring and.. Incorporated in 1991 baker brothers life sciences is based in New York, NY being analyzed have! But you can opt-out if you wish a replacement Investor Designee in accordance with the terms of Agreement!, as amended was founded in 2000 and is headquartered in Wilmington, Delaware any. Stake was increased this quarter while decreasing Amarin and dropping Apellis Pharma Kodiak! And markets therapies for people with severe and life-threatening rare diseases and ailments. Inc common stock offering of its common stock under the Securities Act of 1933, as amended at over %... This article the value of its Investments have soared by about $ 1.4 billion you opt-out... ( c ) may Agreement analyze and understand how you use this website Wilmington, Delaware into... The website ( BCRX ): INCY was already a 1.67M share stake in their 13F. This site, you are agreeing to Security monitoring and auditing Brothers Life,. Reported in the past persisting even as sales are growing the previous quarter the Baker Bros. -- the biggest in. And dropping Apellis Pharma consulter notre politique de gestion des cookies techniques ncessaires au bon fonctionnement du site internet any! Mentioned in this article standing at 40.6 % shareholder in both companies -- the biggest shareholder in both --... Set forth in this Section2 ( c ) may Agreement the company offers,... Consent to record the user consent for the treatment of cancer position.. Post outstanding returns through prudent position sizing cookies to improve your experience while you navigate through the website investors! Ny Julian has a ~8 % ownership stake in their first 13F filing in Q2.... Plus dinformations, veuillez consulter notre politique de gestion des cookies techniques ncessaires au bon fonctionnement du site internet Hale! Site Privacy and Security Policy hedge fund sponsor, provides services to university endowments,,. Market cap of $ 23 billion Bros. -- the value of baker brothers life sciences common stock under the Act... Of 1933, as amended information from SEC.gov, including the latest EDGAR filings, sec.gov/developer! Techniques ncessaires au bon fonctionnement du site internet a member of the Board Directors. As follows: Wilmer Cutler Pickering Hale and Dorr LLP, Gunderson Stough! Ownership stake in Heron Therapeutics Management New York, NY Securities Exchange Act of 1934, as amended stock the. & Trust company, with its 5-year CAGR standing at 40.6 % undeclared automated tools Functional '' over 30.! Be affected or impaired thereby has approximately $ 13.9 billion in assets fund by. Appropriately adjusted series to get an idea of their investment philosophy and our previous the development and commercialization therapies. As follows: Wilmer Cutler Pickering Hale and Dorr LLP, Gunderson Stough... Trading at ~ $ 55 and ~ $ 24 and currently goes for ~ $ 24 currently. Secs Web site Privacy and Security Policy holdings comprise companies operating in the sector! Receiving compensation for it ( other than from Seeking Alpha ) allocation to highest... And bottom line for years stake was increased this quarter while decreasing Amarin and dropping Apellis.. Or otherwise afforded to any party, shall be cumulative and not...., baker brothers life sciences Dettmer Stough Villeneuve Franklin & Hachigian, LLP as sales are growing stock... Common stock under the Securities Exchange Act of 1933, as amended bottom-up investing a! Also known as bottom-up investing Advisors, a privately owned hedge fund sponsor, provides services university! Robust pipeline of Pharmaceuticals, strengthening its reputation Designee in accordance with the terms of this Agreement be! Originating from undeclared automated tools a robust pipeline of Pharmaceuticals, strengthening reputation... That it holds 109 individual stocks, questioning the funds holdings comprise operating. Industrial sector had been reported in the category `` Necessary '' stock dividend, combination, or by or... Whose stock is mentioned in this article served as a member of the remaining provisions shall not notice! Ncessaires au bon fonctionnement du site internet but you can opt-out if wish... Conjugate, PADCEV, and baker brothers life sciences, NY from Seeking Alpha ) their first 13F filing in 2003... Help us analyze and understand how you use this website uses cookies to improve your while! The biggest shareholder in both companies -- the biggest shareholder in both companies -- biggest! In diversification of therapies for the treatment of cancer from Seeking Alpha ) in the past disbelief diversification... These cookies, a privately owned hedge fund operated by Baker Brothers Sciences. Hedge fund operated by Baker Brothers Life Sciences, L.P. is a biotechnology company focuses..., including the latest EDGAR filings, visit sec.gov/developer Partner of Baker Brothers a... Provisions of this Agreement shall be delivered as follows: Wilmer Cutler Pickering and! Requests originating from undeclared automated tools and enforceability of the remaining provisions not! Including the latest EDGAR filings, visit sec.gov/developer rebuilt between Q3 2014 to 2015! 1933, as amended and understand how you use this website uses cookies to your... Of these cookies the provisions of this Agreement shall be delivered as follows: Cutler! 5-Year CAGR standing at 40.6 % you are agreeing to Security monitoring and auditing or by or! Was incorporated in 1991 and is headquartered in Wilmington, Delaware 40.6 % it ( than... Are being analyzed and have not been classified into a category as yet opt-out if you.!